Treatment of Resistant Hypertension: Cohort Study

CompletedOBSERVATIONAL
Enrollment

731

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Resistant Hypertension
Interventions
DRUG

Add-on therapy

Add-on drugs prescribed by internal medicine specialists within the routine health care and independently from the study investigators - one of the following: an aldosterone receptor blocker, a loop diuretic, a thiazide in large daily dose, an alpha 1 selective blocker or a beta 1 selective blocker

Trial Locations (12)

Unknown

Clinical Center of Serbia, Belgrade

Clinical Hospital Center Zemun, Belgrade

Clinical Hospital Center Zvezdara, Belgrade

Medical Military Academy, Belgrade

University Clinical Hospital Center Dragisa Misovic - site 1, Belgrade

University Clinical Hospital Center Dragisa Misovic - site 2, Belgrade

University Hospital Medical Center Bezanijska Kosa, Belgrade

Institute of Cardiovascular Diseases of Vojvodina, Kamenitz

University Clinical Center Kragujevac, Kragujevac

General Hospital Leskovac, Leskovac

Clinical Center Nis, Niš

General Hospital Subotica, Subotica

All Listed Sponsors
collaborator

Medicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)

UNKNOWN

lead

Galenika AD Beograd

INDUSTRY